> Back to EJC

Recent editions

  • May 2016
    Mark Lemmon on the underlying biochemistry of cancer.
  • April 2016
    Roger Stupp on using alternating electric fields as treatment.
  • March 2016
    Charlotte Vrinten on public perception of deaths from cancer.
  • February 2016
    Guillermo Garcia-Manero on myelodysplastic syndromes (MDS).
  • December 2015/January 2016
    Nazneen Rahman on germline genetic screening in ovarian cancer.
  • November 2015
    Caroline Robert on new developments in immunotherapy.
  • October 2015
    Milena Sant on the latest results from the EUROCARE study.
  • September 2015
    The science behind the IARC code that could reduce cancer in Europe.
  • July/August 2015
    Thomas Helleday on an exciting new class of drug, MTH1 inhibitors.
  • June 2015
    Lesley Seymour and Jan Bogaerts on the future of RECIST.
  • May 2015
    Paul Workman on strategies for overcoming resistance to new drugs.
  • April 2015
    Highlights from the TAT Congress in Paris.
  • March 2015
    Christopher Wild on the exposome, a measure of environmental exposure.

> All 2015 Editions

> All 2014 Editions

> All 2013 Editions

> All 2012 Editions

> All 2011 Editions

EJC News Focus – March 2013

Loading EJC News Focus video

'New impetus is needed' to tackle the global burden of childhood cancer

Improvements in child cancer survival rates mean that 80% are now potentially curable with current treatments. Despite this, almost 100,000 children under 15 die from cancer, every year.

In a new Lancet Oncology Series, experts are challenging public policy on childhood cancer and calling for new determination to focus on the specific needs of children and young people with cancer.

In Europe and the States, for example, increasingly strict regulations governing clinical trials and data protection are hampering research and slowing down the development of new treatments for childhood cancers. In poorer countries, the key problem may be poor availability of basic healthcare but much has been achieved in some by politicians motivated to create sustainable infrastructure.

Richard Sullivan (King's Health Partners Integrated Cancer Centre, London) co-edited the series, and is also editor of the new online Journal of Cancer Policy, which will publish follow-up papers on paediatric oncology from this autumn. In this month's EJC News Focus, he tells Helen Saul that the current political climate is 'lukewarm' on the issue of childhood cancer, and why that needs to change.